Press release
Heart Failure Drugs Market to Reach USD 19.4 Billion by 2034
Heart Failure Drugs Market
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/49895
Introduction
The global Heart Failure Drugs Market is entering a high-growth phase as new drug classes transform treatment and survival outcomes for millions worldwide. With cardiovascular diseases continuing to be the leading cause of mortality, the shift toward evidence-backed therapies such as ARNI (angiotensin receptor-neprilysin inhibitors) and SGLT2 inhibitors is reshaping clinical practice. This press release presents the latest market data, developments, and expert insights from Exactitude Consultancy.
Key Takeaways
• Market Size 2024: USD 12.8 Billion
• Forecast for 2034: USD 19.4 Billion
• CAGR (2025-2034): 4.3%
• Growth Accelerators: ARNI adoption, SGLT2 dual-benefit therapy, advanced hospital/clinic infrastructure, and proactive screening programs
• Therapeutic Classes Leading Growth: ARNI, Beta Blockers, SGLT2 inhibitors
• Key Regions: North America leads; Asia-Pacific is the fastest-growing
Explore Full Report here:
https://exactitudeconsultancy.com/reports/49895/heart-failure-drugs-market
Market Story
The Heart Failure Drugs Market is witnessing rapid evolution fuelled by strong clinical evidence supporting new-generation therapies. The introduction of Sacubitril/Valsartan, cardioprotective SGLT2 inhibitors, and combination therapies has significantly improved patient survival and reduced hospitalization rates. Governments and healthcare systems are broadening heart failure screening programs, while pharmaceutical innovation focuses on therapies targeting underlying mechanisms like fibrosis reduction, metabolic modulation, and molecular repair.
In emerging economies, improved diagnostic rates and better treatment affordability are unlocking new opportunities for drug manufacturers. Meanwhile, the global ageing population continues to expand the core patient pool.
Market Segments
By Drug Class
• ACE Inhibitors
• ARNI (Highest Growth Segment)
• SGLT2 Inhibitors
• Beta Blockers
• Aldosterone Antagonists
• Vasodilators
• Diuretics
Growth Insight:
SGLT2 inhibitors and ARNI therapies are projected to grow at over 7% CAGR due to superior outcomes in both HFrEF and HFpEF patients.
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies (Fastest-growing due to convenience and chronic disease home management)
By Region
• North America: Largest market due to drug uptake, rapid regulatory approvals
• Europe: Strong reimbursement support and clinical research presence
• Asia Pacific: Fastest growth driven by expanding cardiac care facilities in India, China, Japan
• South America & Middle East/Africa: Steady growth with improving healthcare accessibility
Recent Developments
• 2024: Multiple clinical trials showed significantly reduced mortality with SGLT2 inhibitors for HF patients with and without diabetes.
• 2025: FDA considering expanded indication for ARNI therapies to include earlier stages of cardiac dysfunction.
• 2025: Leading pharma players launched patient-assistance initiatives across emerging regions to increase adherence.
• 2023-2025: Growing pipeline of anti-fibrotic HF drugs entering Phase 2 and Phase 3 trials.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=49895
Expert Quote
"The Heart Failure Drugs Market is transforming rapidly as ARNI and SGLT2 inhibitors redefine the standard of care. Over the next decade, we expect broader treatment penetration, earlier intervention, and more combination-based drug strategies,"
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Key Market Drivers
• Rising global burden of hypertension, diabetes, and coronary artery disease
• Advancements in guideline-directed medical therapy for HF
• Increasing government funding for cardiovascular care
• Strong clinical evidence supporting new drug classes
• Growing availability of telecardiology and remote prescription services
Forecast & Future Outlook
The Heart Failure Drugs Market will surpass USD 19 billion by 2034, driven by:
• Expanded prescribing of SGLT2 inhibitors for HF across all ejection fractions
• Wider adoption of ARNI therapy as first-line treatment
• Pharma investments in next-gen antifibrotic and regenerative HF therapies
• Integration of digital-health tools for medication adherence monitoring
Asia-Pacific will emerge as the fastest-growing region, contributing the highest incremental revenue by 2034.
Conclusion
As cardiovascular disease rates continue to rise worldwide, the Heart Failure Drugs Market is poised for strong long-term growth. The emergence of highly effective drug classes, combined with supportive healthcare policies and increased patient awareness, will make advanced HF therapies more accessible across global markets.
This report is also available in the following languages : Japanese (心不全治療薬市場), Korean (심부전 치료제 시장), Chinese (心力衰竭药物市场), French (Marché des médicaments contre l'insuffisance cardiaque), German (Markt für Herzinsuffizienzmedikamente), and Italian (Mercato dei farmaci per l'insufficienza cardiaca), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/49895
Our More Reports:
Critical Illness Insurance Market
https://exactitudeconsultancy.com/reports/49887/critical-illness-insurance-market
Neurorehabilitation Gaming Systems Market
https://exactitudeconsultancy.com/reports/49889/neurorehabilitation-gaming-systems-market
Wearable Ambulatory Monitoring Devices Market
https://exactitudeconsultancy.com/reports/49891/wearable-ambulatory-monitoring-devices-market
Asthma Copd Drugs Market
https://exactitudeconsultancy.com/reports/49893/asthma-copd-drugs-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart Failure Drugs Market to Reach USD 19.4 Billion by 2034 here
News-ID: 4268288 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
